Johan Onslev

[Johan Onslev @JohanOnslev]

@DuaneStorey @newjez @Liathetrader @TimurNegru If they are simple cysts of 4 mm, the risk is nowhere near 1%.

[Johan Onslev @JohanOnslev]

@oZChlEQ9frKMQlt Excellent news. Why not Arc X? Same with ECR 2026.

[Johan Onslev @JohanOnslev]

@oZChlEQ9frKMQlt Given their prior history of keeping promises how much should we attribute to this guidance? From a long time NNOX-stockholder.

[Johan Onslev @JohanOnslev]

@AlThingsF1nanc3 P mm kan

[Johan Onslev @JohanOnslev]

@TheAppInvestor Impressive. Do you know if this was developed in-house or just published by $GRVY?

[Johan Onslev @JohanOnslev]

@TheAppInvestor Thanks for the update. What do we expect from further Classic release? Should be interesting in South Korea, Japan and South America if included?

[Johan Onslev @JohanOnslev]

@TheAppInvestor Thanks for the update. At what absolute numbers would you consider the rise in mobile revenue for thunderful significant?

[Johan Onslev @JohanOnslev]

@janthecurious1 Thanks for the update. Looks promising. And what about Google Play grossing? Closing in on a full week to get reliable data.

[Johan Onslev @JohanOnslev]

@janthecurious1 Thank you for the update. Do you know any way to gage the success of Zero on PC?

[Johan Onslev @JohanOnslev]

@TheAppInvestor Perfect, thanks!

[Johan Onslev @JohanOnslev]

@CorleoneDon77 Given the history of Gravity's prior Chinese adventures with most of the income going to the Chinese publisher, do you have any take on this?

[Johan Onslev @JohanOnslev]

@TheAppInvestor Won't this cannibalize the success of Classic?

[Johan Onslev @JohanOnslev]

@KromannTobias Appreciate your thoughts. Why are there both a backlog and an inventory - is the inventory pro and the backlog go?

[Johan Onslev @JohanOnslev]

@cphcompounder Thank you for the information, much appreciated. Any opinion on whether the marked reduction in Tesla price could result in a faster EV-adoption that would favor Zaptec and other charging companies?

[Johan Onslev @JohanOnslev]

@investhornet @wedholm_dennis Yeah, the revenue growth is very impressive, and the margin must have improved significantly as well as you say. Glad to see the company continue its great development. How this updates translates into -5% is a complete mystery, but that's just the current market I guess.

[Johan Onslev @JohanOnslev]

@investhornet @wedholm_dennis That's great news. Thanks alot for sharing the answer.

[Johan Onslev @JohanOnslev]

@investhornet @wedholm_dennis Thank you for your updates, InvestHornet. Any knowledge as to why they haven't released their trading update for last quarter as they usually do within the first 4-5 days of the current quarter?

[Johan Onslev @JohanOnslev]

@TheProjectUnity Afaik this look is due to extensive cellular damage inflicted by rapid decrease in pressure as the blob fish is taken to the surface.

[Johan Onslev @JohanOnslev]

@gamechangercap Guess the bull case is that it actually works in the end.

[Johan Onslev @JohanOnslev]

@gamechangercap Drug development through own 3-headed AI platform analyzing big data, grounded in physiology. Development of personalized immunooncology therapies in cancer and antigen-based vaccines in bacterial infections. Several candidates under development in phase I/IIa/upcoming IIb.